Insights On Pharmaceutical Packaging

  1. A Risk-Based Approach To Injectable Combination Product Development 3/14/2023

    Examine how to establish a holistic approach to drug-device combination product (DDCP) development and how to assess and manage risk throughout the development and approval process.

  2. Highly Flexible And Customizable On-Body Delivery System Platform 6/28/2023

    Learn how Vertiva™ can enable delivery of micro-precision basal doses and full-content bolus injections, resulting in a highly flexible, customizable platform suitable for a wide range of therapies.

  3. Optimal Syringe Carton Design To Meet Drug Manufacturers' Needs 8/1/2024

    Learn about the advantages of an optimal packaging design and the resulting benefits of its implementation to the overall process.

  4. Selecting Container Closure Systems With Confidence: Lyophilization 3/7/2024

    Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.

  5. How DFM Promotes Scalability, Repeatability, And Profitability 6/28/2024

    DFM discussion must be concise and backed by both historical data and up-to-the-minute insights, e.g., discovered through prototyping, test runs, etc.

  6. Lifecycle Planning For Containment And Delivery Of Biologics Drug Products 6/20/2024

    Read more about trends in the biologics market that could impact the lifecycle strategies for your drug product and steps you can take around drug packaging early in development to set yourself up for future success.

  7. Key Considerations When Developing Your Combination Product 2/20/2024

    Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.

  8. Choosing The Right Primary Container And Troubleshooting Issues 8/25/2023

    Selecting the right primary container for an injectable drug product is critical. Discover how to identify relevant testing to de-risk your product development – and quickly uncover causes of failures.

  9. Providing Packing And Blinding Solutions For An Innovative Drug Start-Up 9/13/2024

    Discover how a CDMO with integrated services enabled a botanical drug start-up to commence their Phase I clinical trial, paving the way for further advancement of their innovative botanical drug.

  10. Characterizing The E&L Profile Of Stoppers For Drug Stability 6/11/2024

    The significance of E&L testing lies in its ability to identify potential risks associated with the use of containers and packaging materials in the pharmaceutical industry.